| Primary |
| Product Used For Unknown Indication |
15.8% |
| Oral Candidiasis |
13.4% |
| Drug Use For Unknown Indication |
12.7% |
| Ill-defined Disorder |
9.8% |
| Atrial Fibrillation |
9.1% |
| Fungal Infection |
7.6% |
| Hypertension |
4.5% |
| Tinea Pedis |
4.3% |
| Hyperlipidaemia |
2.5% |
| Drug Exposure During Pregnancy |
2.2% |
| Oral Fungal Infection |
2.2% |
| Skin Candida |
2.2% |
| Angina Pectoris |
2.0% |
| Asthma |
1.8% |
| Myocardial Infarction |
1.8% |
| Candidiasis |
1.6% |
| Cellulitis |
1.6% |
| Cerebral Infarction |
1.6% |
| Constipation |
1.6% |
| Oesophageal Candidiasis |
1.6% |
|
| International Normalised Ratio Increased |
27.8% |
| Drug Interaction |
15.6% |
| Anaphylactoid Reaction |
12.2% |
| Hypoplastic Left Heart Syndrome |
6.1% |
| Haematuria |
4.4% |
| Anaphylactic Reaction |
3.9% |
| Haemorrhage Subcutaneous |
3.3% |
| Haemorrhage |
2.8% |
| Skin Exfoliation |
2.8% |
| Drug Ineffective |
2.2% |
| Epistaxis |
2.2% |
| Haemorrhagic Diathesis |
2.2% |
| Paralysis |
2.2% |
| Wrong Technique In Drug Usage Process |
2.2% |
| Application Site Pain |
1.7% |
| Coagulation Test Abnormal |
1.7% |
| Haematoma |
1.7% |
| Mouth Haemorrhage |
1.7% |
| Prothrombin Time Prolonged |
1.7% |
| Prothrombin Time Ratio Increased |
1.7% |
|
| Secondary |
| Product Used For Unknown Indication |
22.9% |
| Ill-defined Disorder |
15.4% |
| Oral Candidiasis |
9.5% |
| Drug Use For Unknown Indication |
7.2% |
| Drug Exposure During Pregnancy |
5.8% |
| Atrial Fibrillation |
5.0% |
| Fungal Infection |
4.3% |
| Skin Candida |
4.3% |
| Hypertension |
3.3% |
| Hyperlipidaemia |
3.1% |
| Tinea Pedis |
3.1% |
| Sinus Disorder |
2.6% |
| Candidiasis |
2.2% |
| Cellulitis |
2.0% |
| Foetal Exposure During Pregnancy |
1.8% |
| Myocardial Infarction |
1.8% |
| Angina Pectoris |
1.4% |
| Asthma |
1.4% |
| Oral Fungal Infection |
1.4% |
| Keratitis Fungal |
1.3% |
|
| International Normalised Ratio Increased |
25.7% |
| Anaphylactoid Reaction |
12.0% |
| Drug Interaction |
10.9% |
| Hypoplastic Left Heart Syndrome |
6.0% |
| Drug Ineffective |
4.4% |
| Haematuria |
4.4% |
| Anaphylactic Reaction |
3.3% |
| Contusion |
3.3% |
| Oral Candidiasis |
3.3% |
| Somnolence |
3.3% |
| Epistaxis |
2.7% |
| Off Label Use |
2.7% |
| Skin Exfoliation |
2.7% |
| Anaphylactic Shock |
2.2% |
| Blister |
2.2% |
| Haemorrhage Subcutaneous |
2.2% |
| Liver Function Test Abnormal |
2.2% |
| Premature Labour |
2.2% |
| Ventricular Septal Defect |
2.2% |
| Wrong Technique In Drug Usage Process |
2.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
54.3% |
| Drug Use For Unknown Indication |
21.4% |
| Prophylaxis |
3.3% |
| Pain |
2.1% |
| Rheumatoid Arthritis |
1.9% |
| Sepsis |
1.8% |
| Hiv Infection |
1.8% |
| Electrolyte Substitution Therapy |
1.5% |
| Hypertension |
1.5% |
| Depression |
1.4% |
| Nausea |
1.4% |
| Hepatitis C |
1.3% |
| Epilepsy |
0.9% |
| Inflammatory Bowel Disease |
0.9% |
| Constipation |
0.8% |
| Back Pain |
0.8% |
| Insomnia |
0.8% |
| Rash |
0.8% |
| Multiple Myeloma |
0.7% |
| Urinary Tract Infection |
0.7% |
|
| Premature Labour |
12.5% |
| Vomiting |
7.6% |
| Sepsis |
7.1% |
| Toxic Shock Syndrome |
6.5% |
| Meningitis |
6.0% |
| Rash Pruritic |
6.0% |
| Thrombocytopenia |
5.4% |
| Transposition Of The Great Vessels |
4.9% |
| Liver Function Test Abnormal |
4.3% |
| Rash |
4.3% |
| Abdominal Pain |
3.8% |
| Malaise |
3.8% |
| Pneumonia |
3.8% |
| Pyrexia |
3.8% |
| Weight Decreased |
3.8% |
| Confusional State |
3.3% |
| Gingival Hyperplasia |
3.3% |
| Pneumonia Legionella |
3.3% |
| Renal Failure |
3.3% |
| Stillbirth |
3.3% |
|
| Interacting |
| Product Used For Unknown Indication |
63.4% |
| Drug Use For Unknown Indication |
5.2% |
| Fungal Infection |
5.2% |
| Atrial Fibrillation |
4.7% |
| Oral Candidiasis |
4.1% |
| Ill-defined Disorder |
2.3% |
| Prophylaxis |
2.3% |
| Immunosuppression |
1.7% |
| Antiplatelet Therapy |
1.2% |
| Deep Vein Thrombosis |
1.2% |
| Glaucoma |
1.2% |
| Glomerulonephritis Minimal Lesion |
1.2% |
| Hiv Infection |
1.2% |
| Kaposi's Sarcoma |
1.2% |
| Tongue Ulceration |
1.2% |
| Depression |
0.6% |
| Epstein-barr Virus Infection |
0.6% |
| Gastrointestinal Hypermotility |
0.6% |
| Hypercoagulation |
0.6% |
| Hypertension |
0.6% |
|
| Drug Interaction |
27.6% |
| International Normalised Ratio Increased |
27.6% |
| Tongue Ulceration |
10.3% |
| Fungal Infection |
6.9% |
| Oedema Mouth |
6.9% |
| Swollen Tongue |
6.9% |
| Drug Level Increased |
3.4% |
| Hyponatraemia |
3.4% |
| Vomiting |
3.4% |
| Weight Decreased |
3.4% |
|
